Hydraulic properties of the Hemopump HP31: a study of the downstream pressure distribution

@article{Grigioni2001HydraulicPO,
  title={Hydraulic properties of the Hemopump HP31: a study of the downstream pressure distribution},
  author={Mauro Grigioni and Giovanni Carotti and Carla Daniele and Umberto Morbiducci and Costantino Del Gaudio and Giuseppe D'Avenio and Vincenzo Barbaro and Roberto Michele Di Donato},
  journal={2001 Conference Proceedings of the 23rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society},
  year={2001},
  volume={1},
  pages={462-464 vol.1}
}
  • M. Grigioni, G. Carotti, +5 authors R. D. Di Donato
  • Published 25 October 2001
  • 2001 Conference Proceedings of the 23rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society
The Hemopump was commercialized as an useful tool for the left ventricle assistance. Bioengineers and clinicians showed great interest to develop applications and to analyze its hydraulic behaviour; in this work an application for axial pump in different conditions is presented. A study of the spatial pressure distribution generated by the impeller of the Hemopump is investigated in highly accurate steady-flow conditions. The experimental set up adopted for this study consists in a plexiglass… 

Figures from this paper

References

SHOWING 1-10 OF 19 REFERENCES
Hemodynamic Properties of the Hemopump HP14
TLDR
Pump performance is significantly improved by both afterload and hematocrit reduction, showing that the Hemopump HP14 is a valuable alternative to intra-aortic balloon counterpulsation.
Concept, realization, and first in vitro testing of an intraarterial microaxial blood pump.
TLDR
Intravascular operating microaxial pumps have been clinically introduced and have proven to be useful tools for cardiac assist, but a new pump concept is presented and has been refined in the development process.
The Hemopump-a new cardiac prothesis device
TLDR
Clinical trial results thus far indicate these challenges have been well met and that the Hemopump has the potential to become a widely used, safe, and effective clinical device.
Treatment of cardiogenic shock with the Hemopump left ventricular assist device.
TLDR
The Hemopump provides significant hemodynamic support of the patient in cardiogenic shock allowing for recovery from ventricular stunning in marginal ventricles, and that in select patients the Hemopumps may offer a major improvement in survival over conventional therapy.
Left ventricular assistance using a catheter-mounted coaxial flow pump (Hemopump) in a canine model of regional myocardial ischaemia.
TLDR
It was concluded that the Hemopump provides effective global and regional circulatory support in a canine model of severe cardiogenic shock, however, the value of left ventricular support to modify infarct size could not be demonstrated in this experimental model.
Left ventricular assistance with the transthoracic 24F Hemopump for recovery of the failing heart.
TLDR
Left ventricular hypertrophy is a relative contraindication for the use of the Hemopump and the transthoracic Hemopumps is an easy-to-use and reliable assist device.
Fetal cardiac bypass using an in-line axial flow pump to minimize extracorporeal surface and avoid priming volume.
TLDR
Reducing the extracorporeal surface area and avoiding external priming substances preserves placental hemodynamics after fetal cardiac bypass.
Extracorporeal Circulation in Ewe's Foetus: Towards a Reliable Foetal Cardiac Surgery Protocol a Comparison of two Cases
TLDR
The present study confirms the possibility of cardiac intervention in the foetus, and underlines the critical role of minimally invasive protocol to limit both foetal stress and placental dysfunction.
Circulatory support of cardiac interventional procedures with the Hemopump cardiac assist system.
The Hemopump is a catheter-mounted mechanical circulatory assist device which can support the majority of the circulation and significantly reduce left-ventricular work. It can be introduced via a
Effect of the hemopump left ventricular assist device on regional myocardial perfusion and function. Reduction of ischemia during coronary occlusion.
TLDR
Reduced fractional shortening was again seen in nonischemic tissue with Hemopump assist during left anterior descending artery occlusion, and this was often correlated with reduced perfusion.
...
1
2
...